Select Medical Holdings Corporation

NYSE:SEM Rapport sur les actions

Capitalisation boursière : US$4.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Select Medical Holdings Croissance future

Future contrôle des critères 1/6

Select Medical Holdings devrait augmenter ses bénéfices et son chiffre d'affaires de 27.7% et de 4.4% par an respectivement. Le BPA devrait croître de diminuer de 1% par an. Le rendement des capitaux propres devrait être 12.1% dans 3 ans.

Informations clés

10.5%

Taux de croissance des bénéfices

3.2%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.3%
Taux de croissance des recettes4.5%
Rendement futur des capitaux propres9.8%
Couverture par les analystes

Low

Dernière mise à jour21 Aug 2024

Mises à jour récentes de la croissance future

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05
Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Aug 05
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

Jul 19
Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Jul 01
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13
Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26
There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05
Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18
Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Jan 15
We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Dec 31
Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Nov 06
Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16
Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07
Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14
Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29
At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05
Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17
Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20
The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01
Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Select Medical declares $0.125 dividend

Nov 03

These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Nov 01
These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Sep 16
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Adding To Position For Further Upside Capture

Sep 14

Prévisions de croissance des bénéfices et des revenus

NYSE:SEM - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20267,707315N/AN/A2
12/31/20257,331380N/AN/A5
12/31/20247,027360N/AN/A5
6/30/20246,873259288507N/A
3/31/20246,788260241464N/A
12/31/20236,664235353582N/A
9/30/20236,587217191415N/A
6/30/20236,489196177393N/A
3/31/20236,399174128330N/A
12/31/20226,33415394285N/A
9/30/20226,31217521212N/A
6/30/20226,27822319216N/A
3/31/20226,258329-20168N/A
12/31/20216,205389221401N/A
9/30/20216,105415503669N/A
6/30/20215,995415553705N/A
3/31/20215,6643061,0771,224N/A
12/31/20205,5322508821,028N/A
9/30/20205,446206860999N/A
6/30/20205,415162859998N/A
3/31/20205,544155300448N/A
12/31/20195,454143288445N/A
9/30/20195,344136210380N/A
6/30/20195,218138235410N/A
3/31/20195,153140308485N/A
12/31/20185,081133327494N/A
9/30/20184,911207309489N/A
6/30/20184,720193205415N/A
3/31/20184,527189N/A345N/A
12/31/20174,365171N/A238N/A
9/30/20174,30093N/A196N/A
6/30/20174,25982N/A209N/A
3/31/20174,23774N/A180N/A
12/31/20164,217112N/A347N/A
9/30/20164,211121N/A286N/A
6/30/20164,178143N/A312N/A
3/31/20163,973146N/A282N/A
12/31/20153,683127N/A208N/A
9/30/20153,420123N/A222N/A
6/30/20153,165121N/A204N/A
3/31/20153,052119N/A224N/A
12/31/20143,020117N/A171N/A
9/30/20142,997121N/A230N/A
6/30/20142,963118N/A213N/A
3/31/20142,949111N/A188N/A
12/31/20132,938112N/A193N/A
9/30/20132,936122N/A220N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de SEM ( 27.7% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de SEM ( 10.5% par an) devraient croître plus lentement que le marché US ( 15.2% par an).

Croissance élevée des bénéfices: Les bénéfices de SEM devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de SEM ( 4.4% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de SEM ( 4.4% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de SEM devrait être faible dans 3 ans ( 12.1 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y